proxyvotesnow.com

Home › Companies › KORRO BIO INC. › 2024-2025

KORRO BIO INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and KORRO BIO INC.’s Form 8-K, filed 2025-06-11 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 6Reported items
  • 111Asset managers
  • 835Fund votes
  • 2025-06-11Meeting date

Proxy season: 2024-2025 2025-2026

Explore KORRO BIO INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by KORRO BIO INC.

These tallies are KORRO BIO INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-11 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

KORRO BIO INC. — official shareholder meeting results, meeting held 2025-06-11
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Ram Aiyar 7,979,072---- 18,461360,141 Majority: yes
Elect Director: Jean-François Formela 4,986,043---- 3,011,490360,141 Majority: yes
Elect Director: Katharine Knobil 7,980,056---- 17,477360,141 Majority: yes
2) Korro's stockholders approved, in a non-binding, advisory vote, the compensation of Korro's named executive officers. 7,972,38913,99911,145 --360,141 Majority: yes
3) Korro's stockholders approved, in a non-binding, advisory vote, the "1 Year" option for the frequency of future advisory votes on the compensation of Korro's named executive officers. 8,342,6238,3696,682 --0 Majority: yes

Source: KORRO BIO INC., Form 8-K, filed with the SEC on 2025-06-11 — read the filing on EDGAR.

How asset managers voted at the KORRO BIO INC. 2024-2025 meeting

Each item below shows how the 111 asset managers that disclosed a KORRO BIO INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of KORRO BIO INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Non-Binding Advisory Vote to Approve the Compensation of our Named Executive Officers;

SECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.8%

The 110 asset managers below cast 99.9% of the shares they voted on this item FOR (7,812,045 for, 7,059 against).

FOR: 7,812,045 (99.8%)AGAINST: 7,059 (0.1%)ABSTAIN: 5,698 (0.1%)
Largest asset managers voting on “Non-Binding Advisory Vote to Approve the Compensation of our Named Executive Officers;” at KORRO BIO INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Atlas Venture Life Science Advisors, LLC1,137,1490 00For
NEA Management Company, LLC1,092,1300 00For
AllianceBernstein943,4080 00For
Deep Track Capital, LP865,1860 00For
Fidelity781,4600 00For
DRIEHAUS CAPITAL MANAGEMENT LLC545,6890 00For
Qiming U.S. Ventures Management, LLC368,0850 00For
Siren, L.L.C.277,4520 00For
Cormorant Asset Management, LP243,3620 00For
Citadel228,7630 00For
Vanguard185,6100 00For
Aberdeen168,8560 00For
GEODE CAPITAL MANAGEMENT, LLC92,1520 00For
FRANKLIN ADVISERS INC91,7040 00For
Point7274,2060 00For
Principal72,3980 00For
BlackRock68,129230 00For
Ally Bridge Group (NY) LLC59,7230 00For
State Street56,72150 00For
Woodline Partners LP50,0940 00For
Tri Locum Partners LP49,8970 00For
DAFNA Capital Management LLC47,0860 00For
Charles Schwab42,6640 00For
ADAR1 Capital Management, LLC34,8240 00For
FRANKLIN STRATEGIC SERIES33,8000 00For

Showing the 25 largest of 110 asset managers. See all 110 in the interactive database.

2. Non-Binding Advisory Vote on the Frequency of Future Non- Binding Advisory Votes to Approve the Compensation of our Named Executive Officers

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%
FOR: 8,342,623AGAINST: 8,369

KORRO BIO INC.’s own tally for this item (“3) Korro's stockholders approved, in a non-binding, advisory vote, the "1 Year" option for the frequency of future advisory votes on the compensation of Korro's named executive officers.”): 8,342,623 for, 8,369 against, per its Form 8-K filed 2025-06-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 9,390,492 outstanding shares: 89% for, 0.1% against (89% of the company cast a for/against vote).

The 109 asset managers below cast 99.9% of the shares they voted on this item FOR (61,776 for, 42 against).

ONE YEAR 46.6%1 YEAR 37%1YR 15%
FOR: 61,776 (0.8%)AGAINST: 42 (0.0%)ABSTAIN: 5,698 (0.1%)ONE YEAR: 3,476,533 (46.6%)1 YEAR: 2,772,423 (37.2%)1YR: 1,137,149 (15.3%)2 YEARS: 874 (0.0%)3 YEARS: 2 (0.0%)
Largest asset managers voting on “Non-Binding Advisory Vote on the Frequency of Future Non- Binding Advisory Votes to Approve the Compensation o” at KORRO BIO INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Atlas Venture Life Science Advisors, LLC00 001Yr
NEA Management Company, LLC00 001 Year
AllianceBernstein00 00One Year
Deep Track Capital, LP00 001 Year
Fidelity00 00One Year
DRIEHAUS CAPITAL MANAGEMENT LLC00 00One Year
Siren, L.L.C.00 001 Year
Cormorant Asset Management, LP00 001 Year
Citadel00 00One Year
Vanguard00 00One Year
Aberdeen00 00One Year
GEODE CAPITAL MANAGEMENT, LLC00 00One Year
FRANKLIN ADVISERS INC00 00One Year
Point7200 00One Year
Principal00 00One Year
BlackRock00 001 Year
Ally Bridge Group (NY) LLC59,7230 00For
State Street00 00One Year
Woodline Partners LP00 00One Year
Tri Locum Partners LP00 001 Year
DAFNA Capital Management LLC00 001 Year
Charles Schwab00 001 Year
ADAR1 Capital Management, LLC00 00One Year
FRANKLIN STRATEGIC SERIES00 00One Year
ORBIMED ADVISORS LLC00 001 Year

Showing the 25 largest of 109 asset managers. See all 109 in the interactive database.

3. Election of three Class III directors nominated by our board of directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders: Jean-Francois Formela

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

62% Majority: yes · of votes cast

FOR 62%WITHHELD 38%
FOR: 4,986,043WITHHELD: 3,011,490

KORRO BIO INC.’s own tally for this item (“Elect Director: Jean-François Formela”): 4,986,043 for, 3,011,490 withheld, per its Form 8-K filed 2025-06-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 9,390,492 outstanding shares: 53.1% for, 32% withheld (85% of the company cast a for/withheld vote).

The 36 asset managers below cast 100% of the shares they voted on this item FOR (312,897 for, 0 against).

FOR 27%ABSTAIN 73%
FOR: 312,897 (27.2%)ABSTAIN: 835,584 (72.8%)
Largest asset managers voting on “Election of three Class III directors nominated by our board of directors, each to serve for a three-year term” at KORRO BIO INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
AllianceBernstein00 375,1680Abstain
Fidelity76,2920 224,7500Abstain
Vanguard180,5960 00For
Aberdeen00 84,4280Abstain
Principal00 72,3980Abstain
FRANKLIN STRATEGIC SERIES33,8000 00For
Charles Schwab18,2880 00For
DRIEHAUS MUTUAL FUNDS00 13,1950Abstain
QUANTITATIVE MASTER SERIES LLC00 9,6410Abstain
RBB FUND, INC.00 7,2820Abstain
Brighthouse00 5,6990Abstain
Northern Trust00 5,4280Abstain
Equitable00 5,3320Abstain
Lincoln Financial00 4,5000Abstain
BlackRock00 4,0630Abstain
Brinker Capital Destinations Trust00 3,8120Abstain
Global X3,5900 00For
AIG/SunAmerica00 3,1470Abstain
Pacific Life00 3,0290Abstain
Bridge Builder Trust00 2,3610Abstain
John Hancock00 2,2810Abstain
American Century00 1,9980Abstain
Meeder Funds00 1,9310Abstain
ProShares00 1,0180Abstain
DWS00 9660Abstain

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

4. Election of three Class III directors nominated by our board of directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders: Katharine Knobil

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 7,980,056WITHHELD: 17,477

KORRO BIO INC.’s own tally for this item (“Elect Director: Katharine Knobil”): 7,980,056 for, 17,477 withheld, per its Form 8-K filed 2025-06-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 9,390,492 outstanding shares: 85% for, 0.2% withheld (85% of the company cast a for/withheld vote).

The 36 asset managers below cast 100% of the shares they voted on this item FOR (1,142,783 for, 0 against).

FOR 99.5%
FOR: 1,142,783 (99.5%)ABSTAIN: 5,698 (0.5%)
Largest asset managers voting on “Election of three Class III directors nominated by our board of directors, each to serve for a three-year term” at KORRO BIO INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
AllianceBernstein375,1680 00For
Fidelity301,0420 00For
Vanguard180,5960 00For
Aberdeen84,4280 00For
Principal72,3980 00For
FRANKLIN STRATEGIC SERIES33,8000 00For
Charles Schwab18,2880 00For
DRIEHAUS MUTUAL FUNDS13,1950 00For
QUANTITATIVE MASTER SERIES LLC9,6410 00For
RBB FUND, INC.7,2820 00For
Brighthouse10 5,6980Abstain
Northern Trust5,4280 00For
Equitable5,3320 00For
Lincoln Financial4,5000 00For
BlackRock4,0630 00For
Brinker Capital Destinations Trust3,8120 00For
Global X3,5900 00For
AIG/SunAmerica3,1470 00For
Pacific Life3,0290 00For
Bridge Builder Trust2,3610 00For
John Hancock2,2810 00For
American Century1,9980 00For
Meeder Funds1,9310 00For
ProShares1,0180 00For
DWS9660 00For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

5. Election of three Class III directors nominated by our board of directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders: Ram Aiyar

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 7,979,072WITHHELD: 18,461

KORRO BIO INC.’s own tally for this item (“Elect Director: Ram Aiyar”): 7,979,072 for, 18,461 withheld, per its Form 8-K filed 2025-06-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 9,390,492 outstanding shares: 85% for, 0.2% withheld (85% of the company cast a for/withheld vote).

The 36 asset managers below cast 100% of the shares they voted on this item FOR (1,142,185 for, 0 against).

FOR 99.4%
FOR: 1,142,185 (99.5%)ABSTAIN: 6,296 (0.5%)
Largest asset managers voting on “Election of three Class III directors nominated by our board of directors, each to serve for a three-year term” at KORRO BIO INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
AllianceBernstein375,1680 00For
Fidelity301,0420 00For
Vanguard180,5960 00For
Aberdeen84,4280 00For
Principal72,3980 00For
FRANKLIN STRATEGIC SERIES33,8000 00For
Charles Schwab18,2880 00For
DRIEHAUS MUTUAL FUNDS13,1950 00For
QUANTITATIVE MASTER SERIES LLC9,6410 00For
RBB FUND, INC.7,2820 00For
Brighthouse10 5,6980Abstain
Northern Trust5,4280 00For
Equitable5,3320 00For
Lincoln Financial4,5000 00For
BlackRock4,0630 00For
Brinker Capital Destinations Trust3,8120 00For
Global X3,5900 00For
AIG/SunAmerica3,1470 00For
Pacific Life3,0290 00For
Bridge Builder Trust2,3610 00For
John Hancock2,2810 00For
American Century1,9980 00For
Meeder Funds1,9310 00For
ProShares1,0180 00For
DWS9660 00For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

6. Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.

AUDIT-RELATED

100% fund support · no official result

FOR 99.5%

The 36 asset managers below cast 100% of the shares they voted on this item FOR (1,142,783 for, 0 against).

FOR: 1,142,783 (99.5%)ABSTAIN: 5,698 (0.5%)
Largest asset managers voting on “Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for ” at KORRO BIO INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
AllianceBernstein375,1680 00For
Fidelity301,0420 00For
Vanguard180,5960 00For
Aberdeen84,4280 00For
Principal72,3980 00For
FRANKLIN STRATEGIC SERIES33,8000 00For
Charles Schwab18,2880 00For
DRIEHAUS MUTUAL FUNDS13,1950 00For
QUANTITATIVE MASTER SERIES LLC9,6410 00For
RBB FUND, INC.7,2820 00For
Brighthouse10 5,6980Abstain
Northern Trust5,4280 00For
Equitable5,3320 00For
Lincoln Financial4,5000 00For
BlackRock4,0630 00For
Brinker Capital Destinations Trust3,8120 00For
Global X3,5900 00For
AIG/SunAmerica3,1470 00For
Pacific Life3,0290 00For
Bridge Builder Trust2,3610 00For
John Hancock2,2810 00For
American Century1,9980 00For
Meeder Funds1,9310 00For
ProShares1,0180 00For
DWS9660 00For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

Largest KORRO BIO INC. shareholders voting in 2024-2025

Ranked by the number of KORRO BIO INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 9,390,492 shares outstanding at the time of that meeting.

Top KORRO BIO INC. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1Atlas Venture Life Science Advisors, LLC 12.11%
2NEA Management Company, LLC 11.63%
3AllianceBernstein 10.05%
4Deep Track Capital, LP 9.21%
5Fidelity 8.32%
6DRIEHAUS CAPITAL MANAGEMENT LLC 5.81%
7Qiming U.S. Ventures Management, LLC 3.92%
8Siren, L.L.C. 2.95%
9Cormorant Asset Management, LP 2.59%
10Citadel 2.44%

Reported KORRO BIO INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

KORRO BIO INC. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
Lynx1 Capital Management LP 16.38% 13G
Venrock Healthcare Capital Partners III, L.P. 15.85% 13G
New Enterprise Associates 17, L.P. 15.29% 13D
Steven A. Cohen 8.70% 13G
FMR (Fidelity) 6.85% 13F
Point72 5.55% 13F
BlackRock 4.70% 13F
Vanguard Group 4.07% 13F
Citadel Advisors 2.70% 13F
Geode Capital 1.49% 13F

Percentages above are of 9,390,492 shares outstanding, as reported by KORRO BIO INC. on its Form 10-Q dated 2025-05-05 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from KORRO BIO INC.’s 10-Q dated 2025-05-05. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At KORRO BIO INC.'s shareholder meeting held 2025-06-11, in the 2024-2025 proxy season, 111 asset managers reported how they voted in their SEC Form N-PX filings, covering 835 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. KORRO BIO INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — Non-Binding Advisory Vote to Approve the Compensation of our Named Executive Officers; — the reporting funds cast 99.9% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

KORRO BIO INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.